AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row - Yahoo! Finance -BoardProspects

AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row

Yahoo! Finance May 9 2021 BoardNews

Pascal Soriot, as AstraZeneca Executive Director and CEO, during US Senate Finance Committee hearing on drug prices, graphic element on gray Amid mounting scrutiny of AstraZeneca's ( AZ.L ) COVID-19 vaccine, the company's CEO is facing pushback from shareholders over a potential big bump in bonuses. Pascal Soriot is in line for a windfall of between £2.3m ($3.2m) and £12m — a sum that could rise in line with AstraZeneca's share price...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- The Other Duty of Corporate Governance also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- New CEO and Board Research from Stanford and The Miles Group: In Grading CEO Performance, Financials Still Dominate also published in Yahoo! Finance
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- The Horace Mann Companies on Forbes Top 100 Trustworthy Companies in America also published in Yahoo! Finance
- TA Associates announces investment in Flashtalking also mentions Investment
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- activist investor
- Management
- COVID
- COVID-19
- Investment
- Coronavirus
- Investors
- ISS
- Institutional Shareholder Services
- Glass Lewis
- AstraZeneca
- Shareholder
- UK
- Aviva
- Pascal Soriot
- CEO
- 3M
- Bonus
- Bonuses
- Covid-19 vaccine